Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply

Lancet Neurol. 2014 Jun;13(6):540. doi: 10.1016/S1474-4422(14)70097-3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers*
  • Cerebral Amyloid Angiopathy / pathology*
  • Cerebral Amyloid Angiopathy / therapy*
  • Humans

Substances

  • Biomarkers